XIX International AIDS Conference in Washington D.C. Interview with Takayuki Ota from The Scripps Research Institute in La Hoia, San Diego. He is part of the Creative and Novel Ideas in HIV Research Grants Program (CNIHR), a IAS and NIH collaboration.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Gretchen Neigh is a neurologist at Emory University in Atlanta working with basic research on depression. She tells about her current work on depression in HIV positive rats and her future hopes for research in humans.

Closing session of the XIX International AIDS Conference with speakers such as Bill Clinton, the two co-chairs of the conference Elly Katabira and Diane Havlir, US politician Nancy Pelosi, Françoise Barré-Sinoussi, and many activists and community leaders.

XIX International AIDS Conference. Paul Nsubuga Semugoma from the Global Forum on MSM and HIV, talks about the situation of men who have sex with men in Uganda and how stigma and discrimination interferes with the work to prevent HIV and end AIDS.

XIX International AIDS Conference. Interview with Chewe Luo, Senior Adviser on HIV/AIDS at UNICEF in New York. She talks about working with HIV prevention and supporting women's health and the rights of women living with HIV as a first step in ending AIDS.

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

XVII International AIDS Conference in Mexico City. Short interview with Manelisi Dubase from the South African Broadcast Corporation (SABC). He talks about the conference and the need for action to deal with the reality of HIV and AIDS.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Interview with Michel Sidibé who became the Director of UNAIDS in 2009. Here he talks about the importance of the international AIDS conferences for bringing in a human rights perspective on the global HIV/AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with three pioneers in the HIV/AIDS response - Dr Mervyn Silverman, Dr Paul Volberding, and Dr Lars Olof Kallings. They talk about the history of the AIDS movement.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.